|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 185,600.00 KRW | -1.17% |
|
-0.91% | +2.95% |
| Dec. 10 | Celltrion USA, Inc. announced that it expects to receive $532.1 million in funding from Celltrion, Inc. | CI |
| Dec. 10 | Celltrion, Inc. announces Annual dividend | CI |
Company Valuation: Celltrion, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 48,989,351 | 27,592,583 | 23,000,359 | 27,970,378 | 40,365,453 | 40,608,750 | - | - |
| Change | - | -43.68% | -16.64% | 21.61% | 44.32% | 0.6% | - | - |
| Enterprise Value (EV) 1 | 49,090 | 27,117 | 23,236 | 29,280 | 41,531 | 41,621 | 41,530 | 40,318 |
| Change | - | -44.76% | -14.31% | 26.01% | 41.84% | 0.22% | -0.22% | -2.92% |
| P/E ratio | 94.4x | 47.2x | 41.6x | 53.7x | 91.7x | 52.1x | 34.5x | 28.3x |
| PBR | 14.4x | 6.87x | 5.34x | 2.46x | 2.2x | 2.31x | 2.18x | 2.04x |
| PEG | - | 3.8x | -9.54x | -20.3x | -2.1x | 0.6x | 0.7x | 1.3x |
| Capitalization / Revenue | 26.5x | 14.6x | 10.1x | 12.9x | 11.3x | 9.81x | 8.23x | 7.15x |
| EV / Revenue | 26.5x | 14.3x | 10.2x | 13.5x | 11.7x | 10.1x | 8.42x | 7.1x |
| EV / EBITDA | 55.1x | 27.9x | 26.6x | 32.6x | 45.6x | 28.4x | 21.6x | 17.9x |
| EV / EBIT | 68.9x | 36x | 35.9x | 44.9x | 84.4x | 37x | 26.4x | 21.2x |
| EV / FCF | 186x | 46x | -211x | 89.5x | 54.2x | 56x | 39.7x | 34.2x |
| FCF Yield | 0.54% | 2.17% | -0.47% | 1.12% | 1.85% | 1.78% | 2.52% | 2.92% |
| Dividend per Share 3 | - | 660.4 | - | 457.9 | 721.2 | 739.4 | 792.2 | 868.8 |
| Rate of return | - | 0.38% | - | 0.25% | 0.4% | 0.4% | 0.43% | 0.47% |
| EPS 3 | 3,284 | 3,691 | 3,530 | 3,437 | 1,966 | 3,560 | 5,387 | 6,548 |
| Distribution rate | - | 17.9% | - | 13.3% | 36.7% | 20.8% | 14.7% | 13.3% |
| Net sales 1 | 1,849 | 1,891 | 2,284 | 2,176 | 3,557 | 4,140 | 4,933 | 5,679 |
| EBITDA 1 | 891.4 | 972.1 | 873.6 | 897.2 | 910.3 | 1,463 | 1,927 | 2,255 |
| EBIT 1 | 712.1 | 753.9 | 647.2 | 651.5 | 492 | 1,126 | 1,572 | 1,904 |
| Net income 1 | 511.3 | 575.1 | 533.2 | 535.6 | 422.7 | 816.8 | 1,229 | 1,485 |
| Net Debt 1 | 100.4 | -475.5 | 235.5 | 1,310 | 1,165 | 1,013 | 921 | -291.1 |
| Reference price 3 | 309,911.93 | 174,344.89 | 146,978.02 | 184,523.81 | 180,288.46 | 185,600.00 | 185,600.00 | 185,600.00 |
| Nbr of stocks (in thousands) | 158,075 | 158,264 | 156,488 | 151,581 | 223,894 | 218,797 | - | - |
| Announcement Date | 2/22/21 | 2/16/22 | 3/3/23 | 2/29/24 | 2/25/25 | - | - | - |
1KRW in Million2KRW in Billions3KRW
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 52.75x | 10.17x | 28.77x | 0.39% | 27.99B | |
| 36.62x | 5.32x | 17.81x | 0.94% | 46.18B | |
| 31.48x | 3.18x | 13.71x | -.--% | 38.08B | |
| 99.81x | 6.06x | 60.82x | -.--% | 34.38B | |
| 37.77x | 6.11x | 27.77x | -.--% | 15.75B | |
| -14.14x | 5519.7x | -13.33x | -.--% | 15.27B | |
| 28.54x | 2.12x | 10.82x | -.--% | 14.08B | |
| -54.42x | 15.29x | -125.32x | -.--% | 13.03B | |
| -35.51x | 13.39x | -38.25x | -.--% | 12.92B | |
| -46.5x | 10.15x | 36168.69x | -.--% | 12.22B | |
| Average | 13.64x | 559.15x | 3,615.15x | 0.13% | 22.99B | |
| Weighted average by Cap. | 29.76x | 373.12x | 1,932.89x | 0.24% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- A068270 Stock
- Valuation Celltrion, Inc.
Select your edition
All financial news and data tailored to specific country editions
